MedTrace Logo

Neonatal Outcome for Laser Coagulation in Twin-to-twin-transfusion Syndrome

NCT03151915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-01-25

No results posted yet for this study

Summary

Twin-twin transfusion syndrome is one of the most severe complication in monochorionic twin pregnancies and can cause severe impairment of fetal and neonatal outcome. In severe TTTS the fetoscopic laser coagulation is the treatment of choice. Fetoscopic laser coagulation is associated with a morbidity and mortality due to iatronic rupture of membranes as well as iatrogenic placenta insufficiency. This can cause preterm delivery as well as intrauterine fetal demise. An adaption of the fetoscopic tools to reduce the lesions of the amniotic membrane can decrease the risk of PPROM and increase the overall survival.

Conditions

  • TTTS

Sponsors & Collaborators

  • Michael Tchirikov MD, PhD

    lead OTHER

Eligibility

Min Age
17 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-12-01
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03151915 on ClinicalTrials.gov